Ischemic-hypoxic mechanisms leading to hippocampal dysfunction as a consequence of status epilepticus

Epilepsy and Behavior

Volumn 49, Issue , 2015, Pages 47-54

  Lucchi, Chiara ^a   Vinet, Jonathan ^a   Meletti, Stefano ^a   Biagini, Giuseppe ^a,b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b AUSL Modena   (Italy)

Author keywords

Ghrelin; Hippocampus; Laminin; Pilocarpine; Pimonidazole; Status epilepticus; Temporal lobe epilepsy

Indexed keywords

CHOLECYSTOKININ; ENDOTHELIN 1; GLIAL FIBRILLARY ACIDIC PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LAMININ; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; MICROTUBULE ASSOCIATED PROTEIN 2; NEUROPEPTIDE Y; PARVALBUMIN; SOMATOSTATIN; PILOCARPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN HEMORRHAGE; CELL ACTIVATION; CELL LOSS; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENTATE GYRUS; ENZYME ACTIVITY; EPILEPTIC STATE; GRANULE CELL; HIPPOCAMPAL CA3 REGION; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOREACTIVITY; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE CELL NECROSIS; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PYRAMIDAL NERVE CELL; RAT; STRATUM LACUNOSUM MOLECULARE; TEMPORAL LOBE EPILEPSY; UPREGULATION; ANIMAL; BRAIN HYPOXIA; BRAIN ISCHEMIA; CHEMICALLY INDUCED; COMPLICATION; DISEASE MODEL; EPILEPSY, TEMPORAL LOBE; HIPPOCAMPUS; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; EPILEPSY, TEMPORAL LOBE; HIPPOCAMPUS; HYPOXIA, BRAIN; PILOCARPINE; RATS; STATUS EPILEPTICUS;

EID: 84938988139     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2015.04.003     Document Type: Article

References (87)

1. Chungath M., Shorvon S. The mortality and morbidity of febrile seizures. Nat Clin Pract Neurol 2008, 4:610-621.
2. Mathern G.W., Adelson P.D., Cahan L.D., Leite J.P. Hippocampal neuron damage in human epilepsy: Meyer's hypothesis revisited. Prog Brain Res 2002, 135:237-251.
3. Trinka E., Unterrainer J., Haberlandt E., Luef G., Unterberger I., Niedermüller U., et al. Childhood febrile convulsions-which factors determine the subsequent epilepsy syndrome? A retrospective study. Epilepsy Res 2002, 50:283-292.
4. Bruton C.J. The neuropathology of temporal lobe epilepsy 1988, Oxford, New York.
5. Téllez-Zenteno J.F., Hernández-Ronquillo L. A review of the epidemiology of temporal lobe epilepsy. Epilepsy Res Treat 2012, 2012:630853.
6. Thom M. Review: hippocampal sclerosis in epilepsy: a neuropathology review. Neuropathol Appl Neurobiol 2014, 40:520-543.
7. Margerison J.H., Corsellis J.A. Epilepsy and the temporal lobes. A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain 1966, 89:499-530.
8. Bonilha L., Elm J.J., Edwards J.C., Morgan P.S., Hicks C., Lozar C., et al. How common is brain atrophy in patients with medial temporal lobe epilepsy?. Epilepsia 2010, 51:1774-1779.
9. Fountain N.B. Status epilepticus: risk factors and complications. Epilepsia 2000, 41(Suppl. 2):23-30.
10. Sloviter R.S. "Epileptic" brain damage in rats induced by sustained electrical stimulation of the perforant path. I. Acute electrophysiological and light microscopic studies. Brain Res Bull 1983, 10:675-697.
11. Olney J.W., deGubareff T., Sloviter R.S. "Epileptic" brain damage in rats induced by sustained electrical stimulation of the perforant path. II. Ultrastructural analysis of acute hippocampal pathology. Brain Res Bull 1983, 10:699-712.
12. Kong Q., Chang L.C., Takahashi K., Liu Q., Schulte D.A., Lai L., et al. Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection. J Clin Invest 2014, 124:1255-1267.
13. Fujikawa D.G. Neuroprotective effect of ketamine administered after status epilepticus onset. Epilepsia 1995, 36:186-195.
14. Brandt C., Potschka H., Löscher W., Ebert U. N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy. Neuroscience 2003, 118:727-740.
15. Curia G., Longo D., Biagini G., Jones R.S., Avoli M. The pilocarpine model of temporal lobe epilepsy. J Neurosci Methods 2008, 30(172):143-157.
16. Fabene P.F., Merigo F., Galiè M., Benati D., Bernardi P., Farace P., et al. Pilocarpine-induced status epilepticus in rats involves ischemic and excitotoxic mechanisms. PLoS One 2007, 2:e1105.
17. Biagini G., Baldelli E., Longo D., Contri M.B., Guerrini U., Sironi L., et al. Proepileptic influence of a focal vascular lesion affecting entorhinal cortex-CA3 connections after status epilepticus. J Neuropathol Exp Neurol 2008, 67:687-701.
18. Sironi L., Cimino M., Guerrini U., Calvio A.M., Lodetti B., Asdente M., et al. Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage. Arterioscler Thromb Vasc Biol 2003, 23:322-327.
19. Tudela R., Soria G., Pérez-De-Puig I., Ros D., Pavía J., Planas A.M. Infarct volume prediction using apparent diffusion coefficient maps during middle cerebral artery occlusion and soon after reperfusion in the rat. Brain Res 2014, 1583:169-178.
20. Scharfman H.E., Sollas A.L., Smith K.L., Jackson M.B., Goodman J.H. Structural and functional asymmetry in the normal and epileptic rat dentate gyrus. J Comp Neurol 2002, 454:424-439.
21. Gualtieri F., Curia G., Marinelli C., Biagini G. Increased perivascular laminin predicts damage to astrocytes in CA3 and piriform cortex following chemoconvulsive treatments. Neuroscience 2012, 218:278-294.
22. Davies C.A., Loddick S.A., Stroemer R.P., Hunt J., Rothwell N.J. An integrated analysis of the progression of cell responses induced by permanent focal middle cerebral artery occlusion in the rat. Exp Neurol 1998, 154:199-212.
23. Zoli M., Pich E.M., Ferraguti F., Biagini G., Fuxe K., Agnati L.F. Indole-pyruvic acid treatment reduces damage in striatum but not in hippocampus after transient forebrain ischemia in the rat. Neurochem Int 1993, 23:139-148.
24. Agnati L.F., Zoli M., Kurosawa M., Benfenati F., Biagini G., Zini I., et al. A new model of focal brain ischemia based on the intracerebral injection of endothelin-1. Ital J Neurol Sci 1991, 12(3 Suppl. II):49-53.
25. Li L., Lundkvist A., Andersson D., Wilhelmsson U., Nagai N., Pardo A.C., et al. Protective role of reactive astrocytes in brain ischemia. J Cereb Blood Flow Metab 2008, 28:468-481.
26. Lucchi C., Curia G., Vinet J., Gualtieri F., Bresciani E., Locatelli V., et al. Protective but not anticonvulsant effects of ghrelin and JMV-1843 in the pilocarpine model of status epilepticus. PLoS One 2013, 8:e72716.
27. Biagini G., Baldelli E., Longo D., Pradelli L., Zini I., Rogawski M.A., et al. Endogenous neurosteroids modulate epileptogenesis in a model of temporal lobe epilepsy. Exp Neurol 2006, 201:519-524.
28. Biagini G., Longo D., Baldelli E., Zoli M., Rogawski M.A., Bertazzoni G., et al. Neurosteroids and epileptogenesis in the pilocarpine model: evidence for a relationship between P450scc induction and length of the latent period. Epilepsia 2009, 50(Suppl. 1):53-58.
29. Walling S.G., Rigoulot M.A., Scharfman H.E. Acute and chronic changes in glycogen phosphorylase in hippocampus and entorhinal cortex after status epilepticus in the adult male rat. Eur J Neurosci 2007, 26:178-189.
30. Schmidt-Kastner R., Ingvar M. Loss of immunoreactivity for glial fibrillary acidic protein (GFAP) in astrocytes as a marker for profound tissue damage in substantia nigra and basal cortical areas after status epilepticus induced by pilocarpine in rat. Glia 1994, 12:165-172.
31. Ingvar M., Schmidt-Kastner R., Meller D. Immunohistochemical markers for neurons and astrocytes show pan-necrosis following infusion of high-dose NMDA into rat cortex. Exp Neurol 1994, 128:249-259.
32. Urban N.N., Barrionuevo G. Active summation of excitatory postsynaptic potentials in hippocampal CA3 pyramidal neurons. Proc Natl Acad Sci U S A 1998, 95:11450-11455.
33. Urban N.N., Henze D.A., Barrionuevo G. Revisiting the role of the hippocampal mossy fiber synapse. Hippocampus 2001, 11:408-417.
34. Biagini G., D'Arcangelo G., Baldelli E., D'Antuono M., Tancredi V., Avoli M. Impaired activation of CA3 pyramidal neurons in the epileptic hippocampus. Neuromol Med 2005, 7:325-342.
35. Avoli M., D'Antuono M., Louvel J., Köhling R., Biagini G., Pumain R., et al. Network and pharmacological mechanisms leading to epileptiform synchronization in the limbic system. Prog Neurobiol 2002, 68:167-207.
36. Avoli M., Biagini G., de Curtis M. Do interictal spikes sustain seizures and epileptogenesis?. Epilepsy Curr 2006, 6:203-207.
37. Panuccio G., D'Antuono M., de Guzman P., Delannoy L., Biagini G., Avoli M. In vitro ictogenesis and parahippocampal networks in a rodent model of temporal lobe epilepsy. Neurobiol Dis 2010, 39:372-380.
38. Kudin A.P., Kudina T.A., Seyfried J., Vielhaber S., Beck H., Elger C.E., et al. Seizure-dependent modulation of mitochondrial oxidative phosphorylation in rat hippocampus. Eur J Neurosci 2002, 15:1105-1114.
39. Williams J.M., Thompson V.L., Mason-Parker S.E., Abraham W.C., Tate W.P. Synaptic activity-dependent modulation of mitochondrial gene expression in the rat hippocampus. Mol Brain Res 1998, 60:50-56.
40. Szabó A., Kálmán M. Post traumatic lesion absence of β-dystroglycan-immunopositivity in brain vessels coincides with the glial reaction and the immunoreactivity of vascular laminin. Curr Neurovasc Res 2008, 5:206-213.
41. Kálmán M., Mahalek J., Adorján A., Adorján I., Pócsai K., Bagyura Z., et al. Alterations of the perivascular dystrophin-dystroglycan complex following brain lesions: an immunohistochemical study in rats. Histol Histopathol 2011, 26:1435-1452.
42. Willis C.L., Camire R.B., Brule S.A., Ray D.E. Partial recovery of the damaged rat blood-brain barrier is mediated by adherens junction complexes, extracellular matrix remodeling and macrophage infiltration following focal astrocyte loss. Neuroscience 2013, 250:773-785.
43. Biagini G., Zoli M., Torri C., Boschi S., Vantaggiato G., Ballestri M., et al. Protective effects of delapril, indapamide and their combination chronically administered to stroke-prone spontaneously hypertensive rats fed a high-sodium diet. Clin Sci 1997, 93:401-411.
44. Metcalf C.S., Poelzing S., Little J.G., Bealer S.L. Status epilepticus induces cardiac myofilament damage and increased susceptibility to arrhythmias in rats. Am J Physiol Heart Circ Physiol 2009, 297:2120-2127.
45. Weiss N., Miller F., Cazaubon S., Couraud P.O. The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta 1788, 2009:842-857.
46. Yepes M., Sandkvist M., Wong M.K., Coleman T.A., Smith E., Cohan S.L., et al. Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood 2000, 96:569-576.
47. Ryu J.K., Jantaratnotai N., McLarnon J.G. Thalidomide inhibition of vascular remodeling and inflammatory reactivity in the quinolinic acid-injected rat striatum. Neuroscience 2009, 163:601-608.
48. Sarkar S., Raymick J., Schmued L. Temporal progression of kainic acid induced changes in vascular laminin expression in rat brain with neuronal and glial correlates. Curr Neurovasc Res 2012, 9:110-119.
49. Wu J., Hua Y., Keep R.F., Nakamura T., Hoff J.T., Xi G. Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke 2003, 34:2964-2969.
50. Fabene P.F., Navarro Mora G., Martinello M., Rossi B., Merigo F., Ottoboni L., et al. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med 2008, 14:1377-1383.
51. Campos R.R., Tolentino-Silva F.R., Mello L.E. Respiratory pattern in a rat model of epilepsy. Epilepsia 2003, 44:712-717.
52. Pereira de Vasconcelos A., Ferrandon A., Nehlig A. Local cerebral blood flow during lithium-pilocarpine seizures in the developing and adult rat: role of coupling between blood flow and metabolism in the genesis of neuronal damage. J Cereb Blood Flow Metab 2002, 22:196-205.
53. Müller L., Müller S., Sellmann T., Groeneweg L., Tokay T., Köhling R., et al. Effects of oxygen insufflation during pilocarpine-induced status epilepticus on mortality, tissue damage and seizures. Epilepsy Res 2014, 108:90-97.
54. Bateman L.M., Li C.S., Seyal M. Ictal hypoxemia in localization-related epilepsy: analysis of incidence, severity and risk factors. Brain 2008, 131(Pt 12):3239-3245.
55. Ma H., Geneslaw A., Zhao M., Suh M., Perry C., Schwartz T.H. The importance of latency in the focality of perfusion and oxygenation changes associated with triggered afterdischarges in human cortex. J Cereb Blood Flow Metab 2009, 29:1003-1014.
56. Zhao M., Ma H., Suh M., Schwartz T.H. Spatiotemporal dynamics of perfusion and oximetry during ictal discharges in the rat neocortex. J Neurosci 2009, 29:2814-2823.
57. Geneslaw A.S., Zhao M., Ma H., Schwartz T.H. Tissue hypoxia correlates with intensity of interictal spikes. J Cereb Blood Flow Metab 2011, 31:1394-1402.
58. Silas R., Sehgal A., Walker A.M., Wong F.Y. Cerebral oxygenation during subclinical seizures in neonatal hypoxic-ischaemic encephalopathy. Eur J Paediatr Neurol 2012, 16:304-307.
59. Noto T., Furuichi Y., Ishiye M., Matsuoka N., Aramori I., Mutoh S., et al. Temporal and topographic profiles of tissue hypoxia following transient focal cerebral ischemia in rats. J Vet Med Sci 2006, 68:803-807.
60. Noto T., Furuichi Y., Ishiye M., Matsuoka N., Aramori I., Mutoh S., et al. Tacrolimus (FK506) limits accumulation of granulocytes and platelets and protects against brain damage after transient focal cerebral ischemia in rat. Biol Pharm Bull 2007, 30:313-317.
61. Thored P., Wood J., Arvidsson A., Cammenga J., Kokaia Z., Lindvall O. Long-term neuroblast migration along blood vessels in an area with transient angiogenesis and increased vascularization after stroke. Stroke 2007, 38:3032-3039.
62. Bergeron M., Yu A.Y., Solway K.E., Semenza G.L., Sharp F.R. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur J Neurosci 1999, 11:4159-4170.
63. Weinstein P.R., Hong S., Sharp F.R. Molecular identification of the ischemic penumbra. Stroke 2004, 35(Suppl. 1):2666-2670.
64. Faraco G., Fossati S., Bianchi M.E., Patrone M., Pedrazzi M., Sparatore B., et al. High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo. J Neurochem 2007, 103:590-603.
65. Gualtieri F., Marinelli C., Longo D., Pugnaghi M., Nichelli P.F., Meletti S., et al. Hypoxia markers are expressed in interneurons exposed to recurrent seizures. Neuromol Med 2013, 15:133-146.
66. Hempel C., Combes V., Hunt N.H., Kurtzhals J.A., Grau G.E. CNS hypoxia is more pronounced in murine cerebral than noncerebral malaria and is reversed by erythropoietin. Am J Pathol 2011, 179:1939-1950.
67. Maroso M., Balosso S., Ravizza T., Liu J., Aronica E., Iyer A.M., et al. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med 2010, 16:413-419.
68. Helton R., Cui J., Scheel J.R., Ellison J.A., Ames C., Gibson C., et al. Brain-specific knock-out of hypoxia-inducible factor-1α reduces rather than increases hypoxic-ischemic damage. J Neurosci 2005, 25:4099-4107.
69. Kim J.B., Sig Choi J., Yu Y.M., Nam K., Piao C.S., Kim S.W., et al. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci 2006, 26:6413-6421.
70. Henshall D.C., Clark R.S., Adelson P.D., Chen M., Watkins S.C., Simon R.P. Alterations in bcl-2 and caspase gene family protein expression in human temporal lobe epilepsy. Neurology 2000, 55:250-257.
71. Curia G., Lucchi C., Vinet J., Gualtieri F., Marinelli C., Torsello A., et al. Pathophysiogenesis of mesial temporal lobe epilepsy: is prevention of damage antiepileptogenic?. Curr Med Chem 2014, 21:663-688.
72. Biagini G., Torsello A., Marinelli C., Gualtieri F., Vezzali R., Coco S., et al. Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus. Eur J Pharmacol 2011, 670:130-136.
73. Li W.G., Gavrila D., Liu X., Wang L., Gunnlaugsson S., Stoll L.L., et al. Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation 2004, 109:2221-2226.
74. Yang D., Liu Z., Zhang H., Luo Q. Ghrelin protects human pulmonary artery endothelial cells against hypoxia-induced injury via PI3-kinase/Akt. Peptides 2013, 42:112-117.
75. Chung H., Kim E., Lee D.H., Seo S., Ju S., Lee D., et al. Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation. Endocrinology 2007, 148:148-159.
76. Miao Y., Xia Q., Hou Z., Zheng Y., Pan H., Zhu S. Ghrelin protects cortical neuron against focal ischemia/reperfusion in rats. Biochem Biophys Res Commun 2007, 359:795-800.
77. Hwang S., Moon M., Kim S., Hwang L., Ahn K.J., Park S. Neuroprotective effect of ghrelin is associated with decreased expression of prostate apoptosis response-4. Endocr J 2009, 56:609-617.
78. Cheyuo C., Wu R., Zhou M., Jacob A., Coppa G., Wang P. Ghrelin suppresses inflammation and neuronal nitric oxide synthase in focal cerebral ischemia via the vagus nerve. Shock 2011, 35:258-265.
79. Broglio F., Boutignon F., Benso A., Gottero C., Prodam F., Arvat E., et al. EP1572: a novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man. J Endocrinol Invest 2002, 25:RC26-RC28.
80. Piccoli F., Degen L., MacLean C., Peter S., Baselgia L., Larsen F., et al. Pharmacokinetics and pharmacodynamic effects of an oral ghrelin agonist in healthy subjects. J Clin Endocrinol Metab 2007, 92:1814-1820.
81. Du F., Eid T., Lothman E.W., Köhler C., Schwarcz R. Preferential neuronal loss in layer III of the medial entorhinal cortex in rat models of temporal lobe epilepsy. J Neurosci 1995, 15:6301-6313.
82. Yilmazer-Hanke D.M., Wolf H.K., Schramm J., Elger C.E., Wiestler O.D., Blümcke I. Subregional pathology of the amygdala complex and entorhinal region in surgical specimens from patients with pharmacoresistant temporal lobe epilepsy. J Neuropathol Exp Neurol 2000, 59:907-920.
83. Kunz W.S., Kudin A.P., Vielhaber S., Blümcke I., Zuschratter W., Schramm J., et al. Mitochondrial complex I deficiency in the epileptic focus of patients with temporal lobe epilepsy. Ann Neurol 2000, 48:766-773.
84. Mott R.T., Thore C.R., Moody D.M., Glazier S.S., Ellis T.L., Brown W.R. Reduced ratio of afferent to total vascular density in mesial temporal sclerosis. J Neuropathol Exp Neurol 2009, 68:1147-1154.
85. Barbarosie M., Avoli M. CA3-driven hippocampal-entorhinal loop controls rather than sustains in vitro limbic seizures. J Neurosci 1997, 17:9308-9314.
86. D'Arcangelo G., Panuccio G., Tancredi V., Avoli M. Repetitive low-frequency stimulation reduces epileptiform synchronization in limbic neuronal networks. Neurobiol Dis 2005, 19:119-128.
87. Zhong K., Wu D.C., Jin M.M., Xu Z.H., Wang Y., Hou W.W., et al. Wide therapeutic time-window of low-frequency stimulation at the subiculum for temporal lobe epilepsy treatment in rats. Neurobiol Dis 2012, 48:20-26.